CIK 0001873835 · <br>Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454869378
- Phone
- (888) 958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- 8-K Event Other events
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure · Other events
- 10-K/A Report 10-K/A
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
Page 2 of 13 · 244 filings